Skip to main content

Intra-Cellular Therapies, Inc.

ITCIDelisted Apr 2, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001567514

Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding Intra-Cellular Therapies, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ITCI: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1813208+30
Shares68.6M133.0K69.0M+551.2K (+0.8%)
Value$2.56B$4.96M$3.60B+$1.05B (+41.1%)

3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (52)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ITCI in Q4 2021
InstitutionSharesValue% of portfolio
Pictet Asset Management SA1,454,874$76.1M0.08%
GW&K Investment Management, LLC373,320$19.5M0.16%
Two Sigma Investments, LP277,359$14.5M0.04%
D. E. Shaw & Co., Inc.153,587$8.04M0.01%
Assenagon Asset Management S.A.128,111$6.71M0.02%
Sonora Investment Management Group, LLC89,051$4.66M0.54%
Moore Capital Management, LP80,300$4.20M0.11%
Quantum Private Wealth, LLC77,622$4.06M1.54%
Vahanian & Associates Financial Planning Inc.71,742$3.75M3.03%
EAM Global Investors LLC49,768$2.60M0.46%
EAM Investors, LLC42,404$2.22M0.36%
EFG Asset Management (North America) Corp.39,071$2.04M0.27%
B. Metzler seel. Sohn & Co. AG31,831$1.66M0.02%
Atom Investors LP27,553$1.44M0.40%
Tri Locum Partners LP26,177$1.37M0.55%
Rock Creek Group, LP27,543$1.31M0.19%
Schonfeld Strategic Advisors LLC21,715$1.14M0.01%
Kiwi Wealth Investments Limited Partnership20,388$1.07M0.05%
Allspring Global Investments Holdings, LLC19,762$1.03M0.00%
St. Louis Trust Co12,870$674.0K0.14%
Quantbot Technologies LP11,554$604.0K0.05%
Two Sigma Advisers, LP11,467$600.0K0.00%
SeaCrest Wealth Management, LLC10,674$559.0K0.06%
Natixis Advisors, L.P.10,607$555.0K0.00%
Two Sigma Securities, LLC8,779$459.0K0.09%
Guggenheim Capital LLC7,691$402.0K0.00%
Kestra Advisory Services, LLC6,045$316.0K0.00%
Squarepoint Ops LLC5,815$304.0K0.00%
Raymond James Trust N.A.5,343$280.0K0.01%
Y-Intercept (Hong Kong) Ltd5,272$276.0K0.07%
Alpine Woods Capital Investors, LLC4,700$246.0K0.02%
Umb Bank N A4,656$244.0K0.00%
AlphaCrest Capital Management LLC4,600$241.0K0.01%
Janney Montgomery Scott LLC4,157$218.0K0.00%
Aquatic Capital Management LLC4,100$215.0K0.42%
XTX Topco Ltd4,031$211.0K0.12%
Penbrook Management LLC4,000$209.0K0.13%
Stonnington Group, LLC5,050$204.0K0.04%
Mackenzie Financial Corp3,841$201.0K0.00%
PFS Partners, LLC512$26.8K0.02%
Cambridge Trust Co500$26.0K0.00%
Leonteq Securities AG310$16.2K0.00%
Confluence Wealth Services, Inc.192$10.0K0.00%
First Horizon Advisors, Inc.161$7.00K0.00%
Itau Unibanco Holding S.A.112$6.00K0.00%
Assetmark, Inc60$3.00K0.00%
Centerpoint Advisors, LLC35$2.00K0.00%
TD Waterhouse Canada Inc.24$1.07K0.00%
Massmutual Trust Co FSB12$1.00K0.00%
Northwestern Mutual Wealth Management Co10$1.00K0.00%
Covestor Ltd15$1.00K0.00%
CWM, LLC5$00.00%

Sold out (22)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Not filed for Q4 2021 yet (3)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ITCI in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Sonora Investment Management, LLC90,531$3.38M
B. Metzler seel. Sohn & Co. Holding AG42,460$1.58M
Berman Capital Advisors, LLC36$1.00K